dihexa hgf c-met cancer risk

dihexa hgf c-met cancer risk (PNB-0408) | c-Met/HGFR Activator HGF/c-Met pathway facilitates the perineural

Name: dihexa hgf c-met cancer risk (PNB-0408) | c-Met/HGFR Activator HGF/c-Met pathway facilitates the perineural
Brand: astonvaughan.co.uk
SKU: 65685439692
Price: 22.44 USD
Availability: InStock
Rating: 4.3141 (13 reviews)

HGF c Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR NGF axis Cell Death & Disease c MET: A Key Target in Cancer Therapy Dihexa UK: Evidence Based Peptide Research Guide Downstream signalling and specific inhibition of c MET HGF pathway in small cell lung cancer: implications for tumour invasion British Journal of Cancer

SKU: 65685439692 · From astonvaughan.co.uk

4.3

USD22.44 USD51.44

Pay in 4 interest-free payments of $5.61 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion